EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 Diabetes Patients Multi-Center Phase III Trial Planned for 2019 WEST CALDWELL, NJ and TORONTO, ON, May 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical...